Entrepreneurial Spirit, Rooted in Tradition . Tanabe Pharma America, Inc. (“TPA”) is a U.S. subsidiary of Tanabe Pharma Corporation in Japan, which touts a storied reputation more than 300 years in the making. Our parent company - one of Japan’s most respected - is a research-driven pharmaceutical company that has tirelessly pursued medical breakthroughs with global reach. Tanabe Pharma Corporation has discovered and produced several first-in-class medicines for serious diseases, including multiple sclerosis (MS), diabetes mellitus (DM), amyotrophic lateral sclerosis (ALS), and is currently developing medicines in Neurology in Parkinson’s (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology. TPA is rapidly expanding its operations across all functional areas. TPA’s commitment to patients and their communities continues with a robust late-stage pipeline of investigational treatments for difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets. In the United States, TPA launched rare disease treatments including RADICAVA® (edaravone) injectables in 2017 and RADICAVA® (edaravone) oral suspension in 2022. The company handles research, clinical development, sales, marketing, medical affairs, supply chain, and business development functions. TPA is dedicated to improving the treatment environment for those with debilitating diseases, researching on real-world evidence, and creating hope for all facing illness. Tanabe Pharma America, Inc. and Shionogi Inc. have entered into an agreement pursuant to which the global rights to Radicava will transfer to Shionogi. Tanabe Pharma America, Inc. has established a new U.S. subsidiary to manage the Radicava business. Should the transaction close, Shionogi Inc. will acquire the new subsidiary, which will then become a wholly owned Shionogi subsidiary. This position is expected to be transferred to Shionogi upon close of the transaction. The Director, Market Access Execution and Program Mgmt, will serve as a cross-functional leader responsible for the planning, execution, and operational performance of Market Access initiatives supporting Radicava ORS. This role is focused on program management excellence, cross-functional coordination and consultative execution across the Market Access ecosystem, including patient access services, specialty pharmacy and distribution, trade operations, payer execution, and federal channels. The Director will partner closely with Sr. Market Access and Commercial leadership to operationalize approved strategies, ensure alignment across functions and drive disciplined execution against defined objectives, timelines and KPIs. This role plays a critical part in translating strategy into action, proactively identifying execution risks, and ensuring high-quality delivery across all channels.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director